Overview

Rapid Agitation Control With Ketamine in the Emergency Department

Status:
Completed
Trial end date:
2020-03-12
Target enrollment:
Participant gender:
Summary
Compare intramuscular (IM) ketamine to a combination of IM midazolam and haloperidol with regards to the time required for adequate behavioral control, in minutes, in patients presenting to the emergency department with psychomotor agitation and violent behavior.
Phase:
Phase 2
Details
Lead Sponsor:
David Barbic
Collaborators:
Centre for Health Evaluation and Outcome Sciences (CHÉOS)
St Paul's Emergency Department Research Fund
Treatments:
Haloperidol
Haloperidol decanoate
Ketamine
Midazolam